Pulmonx Operating Cycle from 2010 to 2026
| LUNG Stock | USD 1.63 0.01 0.61% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 309.1 | Current Value 296.9 | Quarterly Volatility 96.75737495 |
Check Pulmonx Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pulmonx Corp's main balance sheet or income statement drivers, such as Interest Expense of 4.2 M, Selling General Administrative of 113.8 M or Total Revenue of 101.2 M, as well as many indicators such as Price To Sales Ratio of 3.46, Dividend Yield of 0.0 or PTB Ratio of 1.58. Pulmonx financial statements analysis is a perfect complement when working with Pulmonx Corp Valuation or Volatility modules.
Pulmonx | Operating Cycle | Build AI portfolio with Pulmonx Stock |
The Operating Cycle trend for Pulmonx Corp offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Pulmonx Corp is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Pulmonx Corp's Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Pulmonx Corp over the last few years. It is Pulmonx Corp's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pulmonx Corp's overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Pulmonx Operating Cycle Regression Statistics
| Arithmetic Mean | 291.72 | |
| Geometric Mean | 278.77 | |
| Coefficient Of Variation | 33.17 | |
| Mean Deviation | 79.29 | |
| Median | 219.43 | |
| Standard Deviation | 96.76 | |
| Sample Variance | 9,362 | |
| Range | 298 | |
| R-Value | 0.66 | |
| Mean Square Error | 5,659 | |
| R-Squared | 0.43 | |
| Significance | 0 | |
| Slope | 12.61 | |
| Total Sum of Squares | 149,792 |
Pulmonx Operating Cycle History
About Pulmonx Corp Financial Statements
Pulmonx Corp stakeholders use historical fundamental indicators, such as Pulmonx Corp's Operating Cycle, to determine how well the company is positioned to perform in the future. Although Pulmonx Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pulmonx Corp's assets and liabilities are reflected in the revenues and expenses on Pulmonx Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pulmonx Corp. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 309.10 | 296.90 |
Currently Active Assets on Macroaxis
| VGIAX | Vanguard Growth And | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| ASML | ASML Holding NV |
Check out the analysis of Pulmonx Corp Correlation against competitors. For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Pulmonx have expansion opportunities? Factors like these will boost the valuation of Pulmonx Corp. Expected growth trajectory for Pulmonx significantly influences the price investors are willing to assign. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Pulmonx Corp demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (1.34) | Revenue Per Share | Quarterly Revenue Growth 0.055 | Return On Assets | Return On Equity |
Understanding Pulmonx Corp requires distinguishing between market price and book value, where the latter reflects Pulmonx's accounting equity. The concept of intrinsic value—what Pulmonx Corp's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Pulmonx Corp's price substantially above or below its fundamental value.
Understanding that Pulmonx Corp's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Pulmonx Corp represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Pulmonx Corp's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.